[1]陈远征 陈昱岐 综述,白 南 审校.口服普萘洛尔治疗婴幼儿血管瘤临床应用新进展[J].中国美容医学,2023,(11):189-193.[doi:10.15909/j.cnki.cn61-1347/r.005980]
　CHEN Yuanzheng,CHEN Yuqi,BAI Nan.New Progress in Clinical Application of Oral Propranolol in the Treatment of Infantile Hemangioma[J].Medical Aesthetics and Beauty,2023,(11):189-193.[doi:10.15909/j.cnki.cn61-1347/r.005980]
点击复制

口服普萘洛尔治疗婴幼儿血管瘤临床应用新进展()
分享到：

《中国美容医学》[ISSN:1008-6445/CN:61-1347/R]

卷:
期数:
2023年11期
页码:
189-193
栏目:
出版日期:
2023-11-10

文章信息/Info

Title:
New Progress in Clinical Application of Oral Propranolol in the Treatment of Infantile Hemangioma
文章编号:
1008-6455(2023)11-0189-05
作者:
陈远征1; 2 陈昱岐3 综述; 白 南4 审校
(1.应急管理部应急总医院烧伤整形外科 北京 1000282.临沂市人民医院烧伤整形外科 山东 临沂 2760003.济南外国语 学校 山东 济南 2501084.临沂市人民医院医学美容整形中心 山东 临沂 276000)
Author(s):
CHEN Yuanzheng1; 2; CHEN Yuqi3; BAI Nan4
(1.Department of Burns and Plastic Surgery,Emergency General Hospital of the Ministry of Emergency Management,Beijing 100028,China 2.Department of Burn and Plastic Surgery,Linyi Peoples Hospital,Linyi 276000,Shandong,China 3.Jinan Foreign Language School,Jinan 250108,Shandong,China 4.Department of Aesthetic Plastic Surgery,Linyi Peoples Hospital,Linyi276000,Shandong,China)
关键词:
婴幼儿血管瘤; 普萘洛尔; 治疗剂量; 给药次数; 不良反应; 复发
Keywords:
infantile hemangioma propranolol therapeutic dose administration times adverse reaction recurrence
分类号:
R732.2
DOI:
10.15909/j.cnki.cn61-1347/r.005980
文献标志码:
A
摘要:
婴幼儿血管瘤是最常见的儿童体表软组织良性肿瘤，发病率高、危害大，早期快速增生会造成严重的外观畸形及器官 发育障碍。普萘洛尔已经成为治疗婴幼儿血管瘤的一线药物，但是在临床应用研究中诸多方面存在差异，甚至是争议。为了 促进其合理应用及明确需要进一步研究方向，本文就普萘洛尔治疗婴幼儿血管瘤的治疗剂量、给药次数、药物的不良反应及 影响血管瘤复发的因素等内容进行综述。
Abstract:
Infantile hemangioma is the most common benign tumor of soft tissue in children. It has a high incidence rate and great harm. Early rapid proliferation can cause serious appearance deformity and organ development disorders. Propranolol has become the fi rst-line drug for the treatment of infantile hemangioma, but there are diff erences and even disputes in many aspects of clinical application researches. In order to promote its rational application and clarify the direction of further researches, the treatment dose, administration times ,the adverse reactions of drugs and the factors of aff ecting the recurrence of hemangioma were reviewed.

相似文献/References:

[1]彭慧子,周 林,杨壮群. 口服普萘洛尔治疗婴幼儿体表血管瘤的临床研究[J].中国美容医学,2018,(04):64.
　PENG Hui-zi,ZHOU Lin,YANG Zhuang-qun. Clinical Study of Oral Propranolol Treatment for Superficial Infantile Hemangiomas[J].Medical Aesthetics and Beauty,2018,(11):64.
[2]邹 筠,袁 华,付荣华,等.普萘洛尔治疗婴幼儿血管瘤时机选择及安全性评估的临床研究[J].中国美容医学,2019,(06):78.
　ZOU Yun,YUAN Hua,FU Rong-hua,et al. Clinical Study on Timing and Safety Evaluation of Propranolol in Treatment of Infant Hemangioma[J].Medical Aesthetics and Beauty,2019,(11):78.
[3]徐筑秋 综述,杨晓楠 祁佐良 审校. 西罗莫司治疗卡波西形血管内皮瘤的研究进展[J].中国美容医学,2019,(08):155.
　XU Zhu-qiu,YANG Xiao-nan,QI Zuo-liang. Research Progress of Sirolimus in Kaposiform Hemangioendothelioma Treatment[J].Medical Aesthetics and Beauty,2019,(11):155.
[4] 张宇飞,刘晋灵,王 博,等. 普萘洛尔联合其他治疗措施治疗婴幼儿血管瘤有效率的网状Meta分析[J].中国美容医学,2020,(5):27.
　 ZHANG Yu-fei,LIU Jin-ling,WANG Bo,et al. Effi cient of Propranolol Combined with Other Therapy in the Treatment of InfantileHemangiomas:A Network Meta-analysis[J].Medical Aesthetics and Beauty,2020,(11):27.
[5] 李雪丽,孙小云,尤加锐,等. Cynergy双波长激光联合普萘洛尔治疗婴幼儿浅表性血管瘤[J].中国美容医学,2021,(1):61.
　 LI Xue-li,SUN Xiao-yun,YOU Jia-rui,et al. Analysis of Therapeutic Effect of Cynergy Dual-wavelength Dye Laser Combinedwith Propranolol on Superficial Infantile Hemangioma[J].Medical Aesthetics and Beauty,2021,(11):61.
[6] 周昱川,王 冰,李 红,等. 普萘洛尔治疗婴幼儿血管瘤前后血清中色素上皮衍生因子水平探讨[J].中国美容医学,2021,(5):62.
　 ZHOU Yu-chuan,WANG Bing,LI Hong,et al. Serum levels of Pigment Epithelium-derived Factor before and after PropranololTreatment of Infantile Hemangioma[J].Medical Aesthetics and Beauty,2021,(11):62.
[7] 魏 娜,赵东红,李 江. 普萘洛尔口服联合复方倍他米松注射治疗婴幼儿血管瘤的护理配合探讨[J].中国美容医学,2021,(7):165.
　 WEI Na,ZHAO Dong-Hong,LI Jiang. Nursing Experience of Infantile Hemangioma by Intralesional Injection of PropranololCombined with Compound Betamethasone[J].Medical Aesthetics and Beauty,2021,(11):165.
[8]高倩倩 综述,霍 然审校.婴幼儿血管瘤治疗效果评分系统的研究进展[J].中国美容医学,2022,(7):172.
　GAO Qianqian,HUO Ran.Research Progress in Scoring the Therapeutic Effects of Infantile Hemangiomas[J].Medical Aesthetics and Beauty,2022,(11):172.
[9]陈远征,李 梁,杨青文,等.口服普萘洛尔不同给药次数治疗婴幼儿血管瘤的前瞻性随机对照研究[J].中国美容医学,2023,(8):103.[doi:10.15909/j.cnki.cn61-1347/r.005855]
　HEN Yuanzheng,LI Liang,YANG Qingwen,et al.A Prospective Randomized Controlled Study on Different Administration Frequency of Oral Propranolol in Infantile Hemangiomas[J].Medical Aesthetics and Beauty,2023,(11):103.[doi:10.15909/j.cnki.cn61-1347/r.005855]
[10]孙 恒,倪志福,屈振繁.两种给药方式治疗婴幼儿血管瘤疗效对比研究[J].中国美容医学,2021,(12):86.
　SUN Heng,NI Zhi-fu,QU Zhen-fan.Clinical Comparative Study of Two Drug Administration Methods for Treatment of Infantile Hemangiomas[J].Medical Aesthetics and Beauty,2021,(11):86.

备注/Memo

备注/Memo:
促进其合理应用及明确需要进一步研究方向，本文就普萘洛尔治疗婴幼儿血管瘤的治疗剂量、给药次数、药物的不良反应及
更新日期/Last Update: 2023-12-06